338 related articles for article (PubMed ID: 34209954)
41. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
[TBL] [Abstract][Full Text] [Related]
42. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
Gao J; Fan YZ; Gao SS; Zhang WT
Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
Wang Z; Chen W; Zhang Y; Xu L; Wang Q
J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
[TBL] [Abstract][Full Text] [Related]
44. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
45. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
[TBL] [Abstract][Full Text] [Related]
46. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
47. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
48. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic accuracy of Cyfra 21-1 for head and neck squamous cell carcinoma: a meta-analysis.
Wang YX; Hu D; Yan X
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2383-9. PubMed ID: 24065233
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis.
Guerra EN; Acevedo AC; Leite AF; Gozal D; Chardin H; De Luca Canto G
Oral Oncol; 2015 Sep; 51(9):805-18. PubMed ID: 26170140
[TBL] [Abstract][Full Text] [Related]
51. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
52. MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.
Gao Y; Zhao H; Lu Y; Li H; Yan G
Tumour Biol; 2014 Nov; 35(11):11041-50. PubMed ID: 25095976
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
Ebnoether E; Muller L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
[TBL] [Abstract][Full Text] [Related]
54. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
55. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
56. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
57. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.
Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP
BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631
[TBL] [Abstract][Full Text] [Related]
58. Narrow band imaging in head and neck unknown primary carcinoma: A systematic review and meta-analysis.
Di Maio P; Iocca O; De Virgilio A; Giudice M; Pellini R; D'Ascanio L; Golusiński P; Ricci G; Spriano G
Laryngoscope; 2020 Jul; 130(7):1692-1700. PubMed ID: 31714611
[TBL] [Abstract][Full Text] [Related]
59. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
[TBL] [Abstract][Full Text] [Related]
60. Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis.
Koopaie M; Kolahdooz S; Fatahzadeh M; Manifar S
Cancer Med; 2022 Jul; 11(13):2644-2661. PubMed ID: 35315584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
